tSCS in Children With Spina Bifida

A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.

Inclusion Criteria: * Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist * Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance. * Between the ages of 4 and 17 years of age. * Documented neurogenic bladder dysfunction * On a stable bladder management regimen at least 4-6 weeks prior to the enrollment in the trial Exclusion Criteria: * Severe behavioral or cognitive impairments that preclude participation in the study, in the opinion of the investigator. * Has an active surgery planned for impairments from spina bifida (e.g. tethered cord syndrome surgery or orthopedic surgery) or has had surgery in the last 6 months. * Is pregnant. Pregnancy will be assessed via verbal report. * Open wounds at the thoracic or lumbar spine that precludes transcutaneous stimulation. * Implanted or attached electronic device in any location of the body (e.g. pacemakers, baclofen pumps, or implanted insulin pumps) * Symptomatic urinary tract infection, urinary tract infection for which they are currently receiving treatment, scheduled urological surgery, or inability to perform or receive catheterization.